ReviewChinese medicine2026
Regulatory mechanisms of Traditional Chinese Medicine on gut microbiota in diabetic microvascular complications.
Review in Chinese medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Diabetic microvascular complications are the most common and serious late-stage problems with diabetes patient, while existing antidiabetic treatments still have limited effects in preventing or reversing microvascular damage. Traditional Chinese Medicine (TCM) has been applied in clinical practice for centuries, showing excellent therapeutic effects in alleviating diabetic microvascular complications. Recently, the regulatory effects of gut microbiota, especially concepts such as the "gut-retina axis" and "gut-kidney axis" have been proposed and supported by accumulating experiment, which shows the importance of gut microbiota in microvascular injury. This review focuses on how TCM-gut microbiota interactions contribute to the prevention and treatment of diabetic microvascular complications, reviewing and organizing the latest evidence from experimental and clinical research. We further summarize current limitations in the field and discuss future direction to better uncover the mechanisms of TCM-microbiota interactions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.